New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 7, 2014
16:25 EDTVRTXVertex downgraded to Perform from Outperform at Oppenheimer
Oppenheimer assumed coverage of Vertex with a Perform rating, down from its prior rating was Outperform. The firm believes the focus for Vertex has shifted to its potential in delF508 heterozygous patients, where challenges remain.
News For VRTX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 10, 2015
07:45 EDTVRTXVertex initiated with a Buy at Canaccord
Target $150.
April 9, 2015
10:48 EDTVRTXDeutsche compares PTC Therapeutics to Vertex, boosts target by $40
Subscribe for More Information
07:27 EDTVRTXPTC Therapeutics price target raised to $115 from $75 at Deutsche Bank
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use